Inhibition of noradrenaline-induced lipolysis in hypothyroid subjects by increased  -adrenergic responsiveness. An effect mediated through the reduction of cyclic AMP levels in adipose tissue.
D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000242:Cyclic AMP / Q000096:biosynthesis / Q000494:pharmacology; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000378:metabolism*; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D013268:Stimulation, Chemical; D013806:Theophylline / Q000037:antagonists & inhibitors / Q000494:pharmacology
D011941:Receptors, Adrenergic; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D009638:Norepinephrine; D010646:Phentolamine